Menu
GeneBe

11-6320293-T-C

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4_ModerateBS2

The NM_145040.3(CAVIN3):c.184A>G(p.Ser62Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000326 in 1,566,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000033 ( 0 hom. )

Consequence

CAVIN3
NM_145040.3 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.33
Variant links:
Genes affected
CAVIN3 (HGNC:9400): (caveolae associated protein 3) The protein encoded by this gene was identified as a binding protein of the protein kinase C, delta (PRKCD). The expression of this gene in cultured cell lines is strongly induced by serum starvation. The expression of this protein was found to be down-regulated in various cancer cell lines, suggesting the possible tumor suppressor function of this protein. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity CAVN3_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.12082541).
BS2
High AC in GnomAd at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CAVIN3NM_145040.3 linkuse as main transcriptc.184A>G p.Ser62Gly missense_variant 1/2 ENST00000303927.4
LOC101927825XR_007062569.1 linkuse as main transcriptn.557+596T>C intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CAVIN3ENST00000303927.4 linkuse as main transcriptc.184A>G p.Ser62Gly missense_variant 1/21 NM_145040.3 P1
ENST00000655261.1 linkuse as main transcriptn.61+596T>C intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152174
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000412
AC:
7
AN:
169698
Hom.:
0
AF XY:
0.0000423
AC XY:
4
AN XY:
94526
show subpopulations
Gnomad AFR exome
AF:
0.000110
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000837
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000325
AC:
46
AN:
1414330
Hom.:
0
Cov.:
33
AF XY:
0.0000299
AC XY:
21
AN XY:
701492
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000420
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152174
Hom.:
0
Cov.:
33
AF XY:
0.0000673
AC XY:
5
AN XY:
74348
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000257
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 30, 2024The c.184A>G (p.S62G) alteration is located in exon 1 (coding exon 1) of the PRKCDBP gene. This alteration results from a A to G substitution at nucleotide position 184, causing the serine (S) at amino acid position 62 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.46
Cadd
Benign
23
Dann
Benign
0.88
DEOGEN2
Benign
0.029
T;T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.099
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.69
T;T
M_CAP
Pathogenic
0.34
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.97
T
MutationTaster
Benign
0.81
D;D
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
0.77
N;N
REVEL
Benign
0.045
Sift
Benign
0.48
T;T
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.092
B;.
Vest4
0.13
MutPred
0.31
Loss of glycosylation at S62 (P = 0.0054);Loss of glycosylation at S62 (P = 0.0054);
MVP
0.50
MPC
0.81
ClinPred
0.12
T
GERP RS
4.9
Varity_R
0.17
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs377745802; hg19: chr11-6341523; API